Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies.
about
Cancer Transcriptome Dataset Analysis: Comparing Methods of Pathway and Gene Regulatory Network-Based Cluster Identification.Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.A five-gene based risk score with high prognostic value in colorectal cancer.Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer.
P2860
Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic role of ERBB2, MET ...... ted with anti-EGFR antibodies.
@en
Prognostic role of ERBB2, MET ...... ted with anti-EGFR antibodies.
@nl
type
label
Prognostic role of ERBB2, MET ...... ted with anti-EGFR antibodies.
@en
Prognostic role of ERBB2, MET ...... ted with anti-EGFR antibodies.
@nl
prefLabel
Prognostic role of ERBB2, MET ...... ted with anti-EGFR antibodies.
@en
Prognostic role of ERBB2, MET ...... ted with anti-EGFR antibodies.
@nl
P2093
P2860
P356
P1476
Prognostic role of ERBB2, MET ...... ted with anti-EGFR antibodies.
@en
P2093
Atsuo Takashima
Hirokazu Shoji
Hirokazu Taniguchi
Naoki Takahashi
Natsuko Okita
Satoru Iwasa
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
P2860
P2888
P304
P356
10.1038/BJC.2016.74
P407
P577
2016-03-22T00:00:00Z